Small molecule inhibitors of influenza A RNA-dependent RNA polymerase
US-9315464-B1 · Apr 19, 2016 · US
Small molecule inhibitors of influenza A RNA-dependent RNA polymerase
US10076529B1 · US · B1
| Field | Value |
|---|---|
| Publication number | US-10076529-B1 |
| Application number | US-201615068379-A |
| Country | US |
| Kind code | B1 |
| Filing date | Mar 11, 2016 |
| Priority date | Jan 31, 2013 |
| Publication date | Sep 18, 2018 |
| Grant date | Sep 18, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Compositions, compounds, and methods with significant antiviral effect against RNA viruses and especially orthomyxoviruses are contemplated, and target the viral promoter that is formed by the 5′ and 3′-UTR sequences of the viral genome.
First claim
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical composition comprising N-(4-(N-(quinoxalin-2-yl)sulfamoyl)phenyl)-2-(p-tolyl)quinoline-4-carboxamide; wherein the compound is present in the composition in an amount effective to reduce viral propagation of a virus belonging to the family of an orthomyxoviridae when the composition is administered to a person in need thereof.
Assignees
Inventors
Classifications
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone · CPC title
Physics · mapped topic
Non-condensed quinolines and containing further heterocyclic rings · CPC title
not condensed and containing further heterocyclic rings · CPC title
1,3-Thiazoles · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10076529B1 cover?
- Compositions, compounds, and methods with significant antiviral effect against RNA viruses and especially orthomyxoviruses are contemplated, and target the viral promoter that is formed by the 5′ and 3′-UTR sequences of the viral genome.
- Who is the assignee on this patent?
- Nant Holdings Ip Llc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/635. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).